James N. Woody

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

Ravinder N. Maini, Ferdinand C. Breedveld, Joachim R. Kalden et al. · Arthritis & Rheumatism · 1998 · 1.6K citations

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)

Hendrik M. van Dullemen, Sander J. H. van Deventer, Daan W. Hommes et al. · Gastroenterology · 1995 · 1.1K citations

Inflammation, Autoimmune Disease, Immunology +6

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

Michael J. Elliott, Ravinder N. Maini, Marc Feldmann et al. · Arthritis & Rheumatism · 1993 · 1K citations

Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis

Michael J. Elliott, Ravinder N. Maini, Marc Feldmann et al. · The Lancet · 1994 · 643 citations

Inflammation, Rheumatology, Rheumatoid Disorder +11

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed

Marc Feldmann, Ravinder N. Maini, James N. Woody et al. · The Lancet · 2020 · 550 citations · Full text

Covid-19 Pandemic, Immunology, Clinical Trials +6